CLSN Celsion Corp.
Celsion Corp . is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
Company profile
Ticker
CLSN
Exchange
Website
CEO
Michael H. Tardugno
Employees
Incorporated in
Location
Fiscal year end
Sector
Industry (SEC)
Former names
Cheung Laboratories Inc
SEC CIK
Corporate docs
IRS number
521256615
CLSN stock data
()
Investment data
Securities sold
Number of investors
Calendar
15 May 20
3 Jul 20
31 Dec 20
News
Company financial data Financial data
| Quarter (USD) | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|
| Revenue | 125K | 125K | 125K | 125K | |
| Net income | -5.06M | -3.1M | -5.48M | -5.9M | |
| Diluted EPS | -0.2 | -0.1 | -0.25 | -0.29 | |
| Net profit margin | -4045% | -2482% | -4381% | -4724% | |
| Operating income | -4.77M | -4.75M | -5.39M | -5.57M | |
| Net change in cash | -1.13M | -1.65M | 2.51M | 2.44M | |
| Cash on hand | 5.75M | 6.88M | 8.52M | 6.01M |
| Annual (USD) | Dec 19 | Dec 18 | Dec 17 | Dec 16 | |
|---|---|---|---|---|---|
| Revenue | 500K | 500K | 500K | 500K | |
| Net income | -16.85M | -11.88M | -20.4M | -22.05M | |
| Diluted EPS | -0.77 | -0.68 | -2.72 | -11.89 | |
| Net profit margin | -3370% | -2377% | -4080% | -4411% | |
| Operating income | -20.57M | -21.07M | -18.47M | -20.65M | |
| Net change in cash | -6.48M | 1.91M | 8.82M | -6.64M | |
| Cash on hand | 6.88M | 13.35M | 11.44M | 2.62M |
Financial data from Celsion earnings reports
Recent insider trades
| Date | Owner | Security | Transaction | Code | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|
| 15 Jun 20 | Alberto R Martinez Jr | Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock | Sale back to company | Dispose D | 2.22 | 70,000 | 155.4K | 69,880 |
| 15 Jun 20 | Chow Pok Yu Augustine | Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock | Grant | Aquire A | 2.58 | 70,000 | 180.6K | 143,689 |
| 15 Jun 20 | Chow Pok Yu Augustine | Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock | Grant | Aquire A | 3.66 | 4,000 | 14.64K | 143,689 |
| 15 Jun 20 | Braun Donald P | Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock | Grant | Aquire A | 2.58 | 50,000 | 129K | 111,357 |
| 15 Jun 20 | Braun Donald P | Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock | Sale back to company | Dispose D | 2.22 | 50,000 | 111K | 61,357 |
| 15 Jun 20 | Braun Donald P | Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock | Grant | Aquire A | 3.66 | 4,000 | 14.64K | 111,357 |
| 15 Jun 20 | Alberto R Martinez Jr | Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock | Grant | Aquire A | 2.58 | 70,000 | 180.6K | 139,880 |
| 15 Jun 20 | Chow Pok Yu Augustine | Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock | Sale back to company | Dispose D | 2.22 | 70,000 | 155.4K | 73,689 |
| 15 Jun 20 | Alberto R Martinez Jr | Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock | Grant | Aquire A | 3.66 | 4,000 | 14.64K | 139,880 |
| 15 Jun 20 | Hooper Robert W | Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock | Grant | Aquire A | 2.58 | 70,000 | 180.6K | 139,737 |
Institutional ownership Q1 2020
0.0% owned by funds/institutions
13F holders |
Current |
|---|---|
| Total holders | 1 |
| Opened positions | 0 |
| Closed positions | 1 |
| Increased positions | 0 |
| Reduced positions | 0 |
13F shares |
Current |
|---|---|
| Total value | 0 |
| Total shares | 50 |
| Total puts | 0 |
| Total calls | 0 |
| Total put/call ratio | – |
Largest owners |
Shares | Value |
|---|---|---|
| Old Second National Bank Of Aurora | 50 | $0 |
Financial report summary
?Competition
BSD MedicalManagement Discussion
- For the three months ended March 31, 2020 our net loss was $5.1 million compared to a net loss of $2.4 million for the same three-month period of 2019.
- With $17.5 million in cash, investments, interest receivable and income tax receivable at March 31, 2020, coupled with future sales of the Company’s State of New Jersey net operating losses well as the remaining availability under the Capital on Demand Equity Facility with JonesTrading Institutional Services LLC, the Company believes it has sufficient capital resources to fund its operations through mid-2021.
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
abroad, abundance, accident, acute, Administrationand, afflicted, aid, allotted, American, analyzing, Anderson, announcedleading, automatic, avoid, avoiding, back, Bank, BBA, bed, bill, biosimilar, Bipartisan, Blueprint, Breakthrough, bribe, bring, broadly, bulk, cap, case, cavity, certify, certiorari, chain, Children, circulation, closure, codified, cohort, commerce, communicable, comparison, compartment, complicating, concealing, conclusion, covertly, creation, curtailment, custody, customer, daily, Dassault, defraud, demographic, detail, developmental, device, diminished, disaster, distancing, District, domestic, donut, duty, earthquake, economy, effector, EMA, encased, encourage, encouraged, encouraging, entirety, examining, exciting, experimental, explosion, external, faith, fallen, false, falsifying, family, FCA, feasible, fighting, fire, flood, fluid, formulary, Framework, fraudulent, furlough, gave, generallybut, guilty, heard, HHS, highest, HIPAA, HITECH, hole, Horizonagreed, hour, House, Hubei, IFN, IHC, ill, imaging, immunosuppressive, implanted, impossible, impressive, imprisonment, improperly, incentivize, inclusion, infected, Infiltration, influence, infused, inhaled, injected, inModa, instability, instilled, intent, intention, introduced, invasive, ITT, iv, jointly, kickback, kind, knowingly, labor, liable, lieu, manmade, match, matched, mechanism, Medicaid, medicinal, medicine, Medidata, memory, methodology, microscopic, microscopically, mimic, nanoparticle, necessity, nurse, opt, opted, oral, ORR, outage, outbreak, outpatient, overtly, pandemic, panel, Paycheck, payroll, peritoneal, pharmacoeconomic, placement, play, pocket, pool, Portability, postpone, PPP, predictor, predominantly, preempted, preliminary, prescription, principle, professional, profile, prohibit, pronounced, Province, proximity, qui, readily, reapply, rebate, RECIST, referral, released, reliant, Relief, remanded, remove, removing, remuneration, resection, resolve, respiratory, retroactive, revolutionize, reward, ripple, role, Roswell, routine, running, SBA, SCA, scheme, Senate, shift, shipping, shortage, Silicon, social, Solid, sorting, specialty, spiked, spread, stable, staffing, statute, statutory, stimulate, stimulatory, storage, strong, Sunshine, suppression, surveillance, syndrome, tam, tasked, taxation, Taxpayer, teaching, temporarily, theEuropean, ThermoDox®in, today, traditional, transmission, transmit, transport, travel, trend, TRICARE, trick, trillion, unclear, unconstitutional, underway, unfair, unplanned, unprecedented, unused, urge, user, Valley, valuation, Vanderbilt, variety, vector, VEGF, violate, violating, violation, visible, visit, voluntary, weather, whistleblower, willfully, women, worker, worsen, worsening, Wuhan
Removed:
accounted, advancement, affirmative, allocated, arithmetic, assessed, assist, bankruptcy, bear, collateral, comparative, comprise, compute, consecutive, cure, default, deliver, directing, disclosing, dividend, exceed, exempt, expressed, foreclose, grace, hedging, holding, immunohistochemistry, incremental, incurring, indemnification, indirect, insolvency, insured, jeopardize, lab, liquidate, lowest, mentioned, merge, multiple, NJEDA, notified, occurring, opening, ordinary, origination, Pathological, pattern, preceding, prepay, prepaying, Presidential, qualifying, recapitalization, recognize, reorganization, repeatedly, requested, responsibility, revised, sector, shared, shouldnot, simplify, Simplifying, split, staining, transferred, twelve, Underwritten, VWAP, wrote
Financial reports
10-Q
2020 Q1
Quarterly report
15 May 20
10-K
2019 FY
Annual report
25 Mar 20
10-Q
2019 Q3
Quarterly report
14 Nov 19
10-Q
2019 Q2
Quarterly report
14 Aug 19
10-Q
2019 Q1
Quarterly report
15 May 19
10-K
2018 FY
Annual report
29 Mar 19
10-Q
2018 Q3
Quarterly report
14 Nov 18
10-Q
2018 Q2
Quarterly report
14 Aug 18
10-Q
2018 Q1
Quarterly report
11 May 18
10-K
2017 FY
Annual report
27 Mar 18
Current reports
8-K
Termination of a Material Definitive Agreement
26 Jun 20
8-K
Celsion Corporation Announces Pricing of $10 Million Underwritten Offering of Common Stock
22 Jun 20
8-K
Departure of Directors or Certain Officers
16 Jun 20
8-K
Entry into a Material Definitive Agreement
1 Jun 20
8-K
Celsion Corporation Reports First Quarter 2020 Financial Results and Provides Business Update
15 May 20
8-K
Added Capital Strengthens Balance Sheet, Assures Cash Through Major Phase III OPTIMA Study Data Readout Events
23 Apr 20
8-K
Celsion Corporation Reports 2019 Financial Results and Provides Business Update
25 Mar 20
8-K
Entry into a Material Definitive Agreement
13 Mar 20
8-K
Termination of a Material Definitive Agreement
9 Mar 20
8-K
Celsion Corporation Prices $4.8 Million Registered Direct Offering
3 Mar 20
Registration and prospectus
424B5
Prospectus supplement for primary offering
22 Jun 20
424B5
Prospectus supplement for primary offering
2 Mar 20
424B3
Prospectus supplement
6 Dec 19
S-1/A
IPO registration (amended)
23 Nov 19
S-1
IPO registration
8 Nov 19
S-8
Registration of securities for employees
16 Aug 19
S-8
Registration of securities for employees
16 Aug 19
424B5
Prospectus supplement for primary offering
5 Dec 18
424B5
Prospectus supplement for primary offering
12 Oct 18
S-3/A
Shelf registration (amended)
28 Sep 18
Proxies
DEF 14A
Definitive proxy
29 Apr 20
DEF 14A
Definitive proxy
29 Mar 19
DEF 14A
Definitive proxy
30 Mar 18
DEF 14A
Definitive proxy
4 Apr 17
PRE 14A
Preliminary proxy
20 Mar 17
DEF 14A
Definitive proxy
5 May 16
PRE 14A
Preliminary proxy
25 Apr 16
DEF 14A
Definitive proxy
30 Apr 15
PRE 14A
Preliminary proxy
17 Apr 15
DEF 14A
Definitive proxy
30 Apr 14
Other
EFFECT
Notice of effectiveness
29 Nov 19
CORRESP
Correspondence with SEC
26 Nov 19
EFFECT
Notice of effectiveness
15 Oct 18
CORRESP
Correspondence with SEC
10 Oct 18
EFFECT
Notice of effectiveness
8 Dec 17
CORRESP
Correspondence with SEC
6 Dec 17
CORRESP
Correspondence with SEC
1 Dec 17
UPLOAD
Letter from SEC
28 Nov 17
CORRESP
Correspondence with SEC
22 Nov 17
UPLOAD
Letter from SEC
20 Nov 17
Ownership
4
Celsion / Timothy J Tumminello ownership change
16 Jun 20
4
Celsion / JEFFREY WAYNE CHURCH ownership change
16 Jun 20
4
Celsion / Michael H Tardugno ownership change
16 Jun 20
4
Celsion / Andreas Voss ownership change
16 Jun 20
4
Celsion / Alberto R Martinez Jr ownership change
16 Jun 20
4
Celsion / Robert W Hooper ownership change
16 Jun 20
4
Celsion / Frederick J. Fritz ownership change
16 Jun 20
4
Celsion / Pok Yu Augustine Chow ownership change
16 Jun 20
4
Celsion / Donald P Braun ownership change
16 Jun 20
SC 13G
Celsion CORP
6 Mar 20